Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
TS
Tomoko Suzuki
Senior Manager
Kameda Seika Co., Ltd.
Publications
20
Funding
0
Patents
0
Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan
Hypertension 71 (3), 530-537, 2018
Confirmatory testing in primary aldosteronism
The Journal of Clinical Endocrinology 97 (5), 1688-1694, 2012
Relationship between sickness presenteeism (WHO–HPQ) with depression and sickness absence due to mental disease in a cohort of Japanese workers
Journal of affective disorders 180, 14-20, 2015
High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral …
Diabetes Care 42 (5), 938-945, 2019
Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism
The Journal of Clinical Endocrinology & Metabolism 103 (3), 900-908, 2018
Japanese dietary pattern consistently relates to low depressive symptoms and it is modified by job strain and worksite supports
Journal of Affective Disorders 150 (2), 490-498, 2013
Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism
Clinical Endocrinology 88 (5), 645-651, 2018
Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depression
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 …, 2014
Obesity as a key factor underlying idiopathic hyperaldosteronism
The Journal of Clinical Endocrinology & Metabolism 103 (12), 4456-4464, 2018
Development and validation of subtype prediction scores for the workup of primary aldosteronism
Journal of hypertension 36 (11), 2269-2276, 2018
Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism
Journal of hypertension 37 (7), 1513-1520, 2019
Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism
Clinical endocrinology 83 (4), 462-467, 2015
Optimal cutoff values of WHO-HPQ presenteeism scores by ROC analysis for preventing mental sickness absence in Japanese prospective cohort
PLoS One 9 (10), e111191, 2014
Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function
Hypertension 74 (3), 630-638, 2019
Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism
Clinical Endocrinology 83 (6), 768-773, 2015
Environmental and sociodemographic factors associated with household malaria burden in the Congo
Malaria journal 18, 1-9, 2019
Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism
European Journal of Endocrinology 181 (3), 339-350, 2019
Clinical characteristics and postoperative outcomes of primary aldosteronism in the elderly
The Journal of Clinical Endocrinology & Metabolism 103 (10), 3620-3629, 2018
Predictors of clinical success after surgery for primary aldosteronism in the Japanese nationwide cohort
Journal of the Endocrine Society 3 (11), 2012-2022, 2019
Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism
Journal of the Endocrine Society 2 (8), 893-902, 2018
TS
Tomoko Suzuki
Senior Manager
Kameda Seika Co., Ltd.
Work experience
Kameda Seika Co., Ltd.
Senior Manager
International University of Health and Welfare
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Food Engineering & Processing
Last updated Jun 2024
Report Error
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Subscribe
Company
About
Blog
Careers
Halo Awards
Support
FAQs
Help center
Feature requests
Contact support
Sponsors
Customer stories
Privacy Policy
Terms of Service
© 2026 Halo Cures, Inc.